Artal Group as of Dec. 31, 2019
Portfolio Holdings for Artal Group
Artal Group holds 91 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ww Intl (WW) | 21.9 | $566M | 15M | 38.21 | |
| Lexicon Pharmaceuticals (LXRX) | 9.7 | $250M | 60M | 4.15 | |
| Alnylam Pharmaceuticals (ALNY) | 4.5 | $115M | 1.0M | 115.17 | |
| Beigene (BGNE) | 4.1 | $106M | 640k | 165.76 | |
| Morgan Stanley (MS) | 4.0 | $102M | 2.0M | 51.12 | |
| Moderna (MRNA) | 3.9 | $100M | 5.1M | 19.56 | |
| Alibaba Group Holding (BABA) | 3.7 | $95M | 450k | 212.10 | |
| Biontech Se (BNTX) | 3.4 | $89M | 2.6M | 33.88 | |
| Avantor (AVTR) | 3.3 | $86M | 4.8M | 18.15 | |
| Acceleron Pharma | 2.5 | $64M | 1.2M | 53.02 | |
| Argenx Se (ARGX) | 2.2 | $56M | 350k | 160.52 | |
| Epizyme | 2.1 | $55M | 2.3M | 24.60 | |
| Fate Therapeutics (FATE) | 1.7 | $43M | 2.2M | 19.57 | |
| Blueprint Medicines (BPMC) | 1.6 | $40M | 500k | 80.11 | |
| Zillow Group Inc Cl C Cap Stk (Z) | 1.3 | $35M | 750k | 45.94 | |
| Amicus Therapeutics (FOLD) | 1.3 | $34M | 3.5M | 9.74 | |
| Scholar Rock Hldg Corp (SRRK) | 1.3 | $34M | 2.5M | 13.18 | |
| Morphic Hldg (MORF) | 1.2 | $31M | 1.8M | 17.16 | |
| Agios Pharmaceuticals (AGIO) | 1.1 | $29M | 600k | 47.75 | |
| Atara Biotherapeutics (ATRA) | 1.1 | $29M | 1.8M | 16.47 | |
| Rubius Therapeutics | 1.0 | $27M | 2.8M | 9.50 | |
| Gossamer Bio (GOSS) | 1.0 | $25M | 1.6M | 15.63 | |
| Paypal Holdings (PYPL) | 0.8 | $22M | 200k | 108.17 | |
| Xencor (XNCR) | 0.7 | $19M | 550k | 34.39 | |
| Turning Point Therapeutics I | 0.7 | $19M | 300k | 62.29 | |
| Aravive | 0.7 | $19M | 1.4M | 13.67 | |
| Clovis Oncology | 0.7 | $18M | 1.8M | 10.42 | |
| Fibrogen (FGEN) | 0.7 | $17M | 400k | 42.89 | |
| Stoneco (STNE) | 0.6 | $16M | 400k | 39.89 | |
| Deciphera Pharmaceuticals (DCPH) | 0.6 | $16M | 250k | 62.24 | |
| Uber Technologies (UBER) | 0.6 | $15M | 500k | 29.74 | |
| American Airls (AAL) | 0.6 | $14M | 500k | 28.68 | |
| Ascendis Pharma A S (ASND) | 0.5 | $14M | 100k | 139.12 | |
| Iovance Biotherapeutics (IOVA) | 0.5 | $14M | 500k | 27.68 | |
| Tricida | 0.5 | $14M | 360k | 37.74 | |
| Springworks Therapeutics (SWTX) | 0.5 | $14M | 350k | 38.49 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.5 | $13M | 1.3M | 9.91 | |
| Harpoon Therapeutics | 0.5 | $13M | 850k | 14.79 | |
| Y Mabs Therapeutics (YMAB) | 0.5 | $13M | 400k | 31.25 | |
| Hookipa Pharma Inc equity (HOOK) | 0.5 | $12M | 1.0M | 12.23 | |
| Albireo Pharma | 0.4 | $11M | 450k | 25.42 | |
| Dicerna Pharmaceuticals | 0.4 | $11M | 500k | 22.03 | |
| Nektar Therapeutics (NKTR) | 0.4 | $11M | 500k | 21.59 | |
| Sage Therapeutics (SAGE) | 0.4 | $11M | 150k | 72.19 | |
| Agenus (AGEN) | 0.4 | $10M | 2.5M | 4.07 | |
| Accelr8 Technology | 0.4 | $10M | 600k | 16.90 | |
| Reata Pharmaceuticals Inc Cl A | 0.4 | $10M | 50k | 204.44 | |
| Incyte Corporation (INCY) | 0.3 | $8.7M | 100k | 87.32 | |
| Bluebird Bio (BLUE) | 0.3 | $8.8M | 100k | 87.75 | |
| BioMarin Pharmaceutical (BMRN) | 0.3 | $8.5M | 100k | 84.55 | |
| Ac Immune Sa (ACIU) | 0.3 | $8.5M | 1.0M | 8.52 | |
| Replimune Group (REPL) | 0.3 | $8.6M | 600k | 14.35 | |
| Selecta Biosciences (RNAC) | 0.3 | $8.1M | 3.4M | 2.38 | |
| Solid Biosciences | 0.3 | $8.0M | 1.8M | 4.45 | |
| Tg Therapeutics (TGTX) | 0.3 | $7.2M | 650k | 11.10 | |
| Minerva Neurosciences | 0.3 | $7.1M | 1.0M | 7.11 | |
| Merus N V (MRUS) | 0.3 | $7.0M | 500k | 14.08 | |
| Denali Therapeutics (DNLI) | 0.3 | $7.0M | 400k | 17.42 | |
| Nio Inc spon ads (NIO) | 0.3 | $7.0M | 1.8M | 4.02 | |
| Bridgebio Pharma (BBIO) | 0.3 | $7.0M | 200k | 35.05 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.2 | $6.6M | 500k | 13.20 | |
| Immunic (IMUX) | 0.2 | $6.1M | 630k | 9.70 | |
| Regenxbio Inc equity us cm (RGNX) | 0.2 | $5.9M | 145k | 40.97 | |
| Tcr2 Therapeutics Inc cs | 0.2 | $5.7M | 400k | 14.28 | |
| Igm Biosciences (IGMS) | 0.2 | $5.7M | 150k | 38.16 | |
| Kura Oncology (KURA) | 0.2 | $5.5M | 400k | 13.75 | |
| Lions Gate Entmnt Corp cl a vtg (LGF.A) | 0.2 | $5.3M | 500k | 10.66 | |
| Translate Bio | 0.2 | $5.3M | 650k | 8.14 | |
| Spero Therapeutics (SPRO) | 0.2 | $4.8M | 500k | 9.62 | |
| Orchard Therapeutics Plc ads | 0.2 | $4.8M | 350k | 13.75 | |
| Prothena (PRTA) | 0.2 | $4.7M | 300k | 15.83 | |
| Krystal Biotech (KRYS) | 0.2 | $4.4M | 80k | 55.38 | |
| 111 Inc ads (YI) | 0.2 | $4.4M | 650k | 6.73 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.2 | $4.5M | 150k | 29.92 | |
| D Stemline Therapeutics | 0.1 | $3.8M | 360k | 10.63 | |
| Alector (ALEC) | 0.1 | $3.9M | 225k | 17.23 | |
| Realreal (REAL) | 0.1 | $3.8M | 200k | 18.85 | |
| Karuna Therapeutics Ord | 0.1 | $3.8M | 50k | 75.34 | |
| Cyclerion Therapeutics | 0.1 | $3.7M | 1.4M | 2.72 | |
| Sangamo Biosciences (SGMO) | 0.1 | $3.4M | 405k | 8.37 | |
| Douyu International Holdings | 0.1 | $3.4M | 400k | 8.47 | |
| Viking Therapeutics (VKTX) | 0.1 | $2.8M | 350k | 8.02 | |
| Intellia Therapeutics (NTLA) | 0.1 | $2.9M | 200k | 14.67 | |
| Akebia Therapeutics (AKBA) | 0.1 | $2.7M | 425k | 6.32 | |
| Curis | 0.1 | $2.6M | 1.5M | 1.70 | |
| Kaleido Biosciences Ord (KLDO) | 0.1 | $2.5M | 501k | 5.02 | |
| Aeglea Biotherapeutics | 0.1 | $2.3M | 300k | 7.64 | |
| Twist Bioscience Corp (TWST) | 0.1 | $2.1M | 100k | 21.00 | |
| Axcella Health Inc equity | 0.1 | $1.8M | 450k | 4.01 | |
| Ironwood Pharmaceuticals (IRWD) | 0.1 | $1.5M | 111k | 13.31 | |
| Aduro Biotech | 0.1 | $1.2M | 1.0M | 1.18 |
